Resolving complexity in mitochondrial disease: Towards precision medicine.

Area of Science:

• Genetics
• Neurology
• Metabolic Disorders

Background:

• Mitochondrial diseases are common inherited neurometabolic disorders stemming from nuclear or mitochondrial DNA (mtDNA) mutations.
• These conditions present significant heterogeneity in clinical symptoms and genetic causes, complicating diagnosis and research.
• Mitochondrial genetics adds complexity, positioning these disorders within the realm of complex diseases.

Purpose of the Study:

• To review the m.3243A>G variant, a prevalent mtDNA mutation, as an exemplar of challenges in mitochondrial disease.
• To explore the causes of phenotypic diversity in m.3243A>G related diseases, including heteroplasmy and nuclear factors.
• To discuss the clinical implications and personalized management of common manifestations linked to the m.3243A>G variant.

Main Methods:

• Literature review focusing on the m.3243A>G mitochondrial DNA variant.
• Analysis of factors contributing to phenotypic heterogeneity (mtDNA heteroplasmy, copy number, nuclear genetics).
• Discussion of clinical manifestations and personalized management strategies.

Main Results:

• The m.3243A>G variant is associated with highly diverse phenotypes, including hearing impairment, diabetes, myopathy, cardiac issues, stroke-like episodes, and GI problems.
• Heteroplasmy, mtDNA copy number, and nuclear genetic factors contribute significantly to this observed heterogeneity.
• Personalized management approaches are crucial for addressing the varied clinical manifestations.

Conclusions:

• Understanding the heterogeneity of mitochondrial diseases, exemplified by m.3243A>G, is critical for effective clinical practice.
• Future research should leverage large patient cohorts to address complexity and improve diagnostic and therapeutic strategies.
• Multi-disciplinary collaboration is essential for developing tailored approaches to manage individual patient needs in complex mitochondrial disorders.